Do statins cut breast cancer recurrence? - Health News - NHS Choices - statins and breast cancer

Category

statins and breast cancer - Effect of Statins on Breast Cancer Recurrence and Mortality: A Review - Oncology Nurse Advisor


Jul 30, 2015 · The connection between statins and breast cancer risk does appear to be stronger than with other cancers. If you’re at high risk for breast cancer, particularly if there’s a family history of Author: James Roland. INTRODUCTION. Many in vitro and animal studies suggest that statin drugs suppress breast cancer progression. In human subjects, little evidence supports a protective effect of statins on breast cancer incidence, but consistent evidence supports a protective effect on disease recurrence.The case for adjuvant breast cancer therapy with statins is unlikely to be advanced by new observational Cited by: 107.

However, current evidence cannot exclude an increased risk of breast cancer with statin use in subsets of individuals, for example, the elderly. On the other hand, some studies show that statins might be useful to prevent recurrence and improve survival in patients already suffering from certain breast cancer . Jun 01, 2016 · June 1, 2016 -- Some women who have survived breast cancer could one day be prescribed statins along with other treatments to keep the cancer Author: Peter Russell.

Jan 05, 2018 · the Oncology Nurse Advisor take: According to a review published in Breast Cancer: Targets and Therapy, statins may be a potential therapeutic option to improve outcomes for patients with breast. According to the doctors, an inspection of the statin trials revealed the specific populations at risk for developing incident cancer with statin treatment included the elderly and people with a history of breast or prostate cancer.

Oct 31, 2011 · “A daily dose of drugs designed to lower cholesterol could also slash the risk of breast cancer recurring,” the Daily Mail reported today. The news is based on the findings of a large Danish study that looked for an association between the use of statins and the recurrence of breast cancer. Reducing cholesterol levels may inhibit breast cancer development, but the long-term use of cholesterol-lowering statin drugs is associated with more than double the risk of both types of breast cancer: invasive ductal carcinoma and invasive lobular carcinoma.4.8/5(9).

Statins' known benefits in preventing cardiovascular disease, along with years of strong evidence that these agents are relatively safe, have led researchers to explore whether statins have the potential to prevent cancer. People should not take statins for cancer prevention outside of a clinical trial.